Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study

Emilia Cercenado, Luis Alcalá, Álvaro Irigoyen-von-Sierakowski, Belén Rodríguez-Sánchez, Mercedes Marín, JA Lepe, JM Marimón, AI López-Calleja, P Palacián-Ruiz, A Canut, A Gimeno, JC Rodríguez, N Tormo, C Gimeno, F Tubau, C Pitart, F Marco, B Nogueira, S Capilla, M Espasa, J Villa, A González-Torralba, C Campelo, FJ Chamizo, F García-Garrote, J Pita, JL Barrios, C Colmenarejo, E Recacha, A Pascual, S Giner, JL López-Hontangas, C Fernández, G Bou, M García-Castillo, D Gijón, R Cantón, X Mulet, N Larrosa, B Vinado, M Martínez, C Rodríguez-Lucas, C Raya, V Ortiz de la Tabla, MV García-López, A Rivera, I Arregui, F Galán, L Barrado, M López-Lomba, F Fernández, C Sáinz de Baranda, C Guerrero, FJ Vasallo, I Gracia, J Calvo, MJ Reina, B Palop, A Rodrigo, E León, J Colomina, D Navarro, JL Muñoz Bellido, P Soria-Lozano, C Aldea, FJ Castillo, C De las Cuevas, L Cardeñoso, ML Pérez del Molino, A Coira, E Garduño, M Rúa-Gómez, J Leiva, MI Sánchez-Romero, L Moreno, G Yagüe, MC Pérez-Seco, RE Rodríguez, N Arenal, MD Quesada, S Ramón, N Prim, E Cercenado, L Alcalá, A Irigoyen-von-Sierakowski, B Rodríguez-Sánchez, M Marín

Open source

DOI
10.1016/j.ijantimicag.2025.107534
Published
2025-09
Container
International Journal of Antimicrobial Agents
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijantimicag.2025.107534,
  title = {Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study},
  author = {Emilia Cercenado and Luis Alcalá and Álvaro Irigoyen-von-Sierakowski and Belén Rodríguez-Sánchez and Mercedes Marín and JA Lepe and JM Marimón and AI López-Calleja and P Palacián-Ruiz and A Canut and A Gimeno and JC Rodríguez and N Tormo and C Gimeno and F Tubau and C Pitart and F Marco and B Nogueira and S Capilla and M Espasa and J Villa and A González-Torralba and C Campelo and FJ Chamizo and F García-Garrote and J Pita and JL Barrios and C Colmenarejo and E Recacha and A Pascual and S Giner and JL López-Hontangas and C Fernández and G Bou and M García-Castillo and D Gijón and R Cantón and X Mulet and N Larrosa and B Vinado and M Martínez and C Rodríguez-Lucas and C Raya and V Ortiz de la Tabla and MV García-López and A Rivera and I Arregui and F Galán and L Barrado and M López-Lomba and F Fernández and C Sáinz de Baranda and C Guerrero and FJ Vasallo and I Gracia and J Calvo and MJ Reina and B Palop and A Rodrigo and E León and J Colomina and D Navarro and JL Muñoz Bellido and P Soria-Lozano and C Aldea and FJ Castillo and C De las Cuevas and L Cardeñoso and ML Pérez del Molino and A Coira and E Garduño and M Rúa-Gómez and J Leiva and MI Sánchez-Romero and L Moreno and G Yagüe and MC Pérez-Seco and RE Rodríguez and N Arenal and MD Quesada and S Ramón and N Prim and E Cercenado and L Alcalá and A Irigoyen-von-Sierakowski and B Rodríguez-Sánchez and M Marín},
  year = {2025},
  journal = {International Journal of Antimicrobial Agents},
  doi = {10.1016/j.ijantimicag.2025.107534},
  url = {https://doi.org/10.1016/j.ijantimicag.2025.107534}
}

RIS

TY  - JOUR
TI  - Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study
AU  - Emilia Cercenado
AU  - Luis Alcalá
AU  - Álvaro Irigoyen-von-Sierakowski
AU  - Belén Rodríguez-Sánchez
AU  - Mercedes Marín
AU  - JA Lepe
AU  - JM Marimón
AU  - AI López-Calleja
AU  - P Palacián-Ruiz
AU  - A Canut
AU  - A Gimeno
AU  - JC Rodríguez
AU  - N Tormo
AU  - C Gimeno
AU  - F Tubau
AU  - C Pitart
AU  - F Marco
AU  - B Nogueira
AU  - S Capilla
AU  - M Espasa
AU  - J Villa
AU  - A González-Torralba
AU  - C Campelo
AU  - FJ Chamizo
AU  - F García-Garrote
AU  - J Pita
AU  - JL Barrios
AU  - C Colmenarejo
AU  - E Recacha
AU  - A Pascual
AU  - S Giner
AU  - JL López-Hontangas
AU  - C Fernández
AU  - G Bou
AU  - M García-Castillo
AU  - D Gijón
AU  - R Cantón
AU  - X Mulet
AU  - N Larrosa
AU  - B Vinado
AU  - M Martínez
AU  - C Rodríguez-Lucas
AU  - C Raya
AU  - V Ortiz de la Tabla
AU  - MV García-López
AU  - A Rivera
AU  - I Arregui
AU  - F Galán
AU  - L Barrado
AU  - M López-Lomba
AU  - F Fernández
AU  - C Sáinz de Baranda
AU  - C Guerrero
AU  - FJ Vasallo
AU  - I Gracia
AU  - J Calvo
AU  - MJ Reina
AU  - B Palop
AU  - A Rodrigo
AU  - E León
AU  - J Colomina
AU  - D Navarro
AU  - JL Muñoz Bellido
AU  - P Soria-Lozano
AU  - C Aldea
AU  - FJ Castillo
AU  - C De las Cuevas
AU  - L Cardeñoso
AU  - ML Pérez del Molino
AU  - A Coira
AU  - E Garduño
AU  - M Rúa-Gómez
AU  - J Leiva
AU  - MI Sánchez-Romero
AU  - L Moreno
AU  - G Yagüe
AU  - MC Pérez-Seco
AU  - RE Rodríguez
AU  - N Arenal
AU  - MD Quesada
AU  - S Ramón
AU  - N Prim
AU  - E Cercenado
AU  - L Alcalá
AU  - A Irigoyen-von-Sierakowski
AU  - B Rodríguez-Sánchez
AU  - M Marín
PY  - 2025
JO  - International Journal of Antimicrobial Agents
DO  - 10.1016/j.ijantimicag.2025.107534
UR  - https://doi.org/10.1016/j.ijantimicag.2025.107534
ER  - 

APA

Cercenado, E., Alcalá, L., Irigoyen-von-Sierakowski, Á., Rodríguez-Sánchez, B., Marín, M., Lepe, J., Marimón, J., López-Calleja, A., Palacián-Ruiz, P., Canut, A., Gimeno, A., Rodríguez, J., Tormo, N., Gimeno, C., Tubau, F., Pitart, C., Marco, F., Nogueira, B., Capilla, S., Espasa, M., Villa, J., González-Torralba, A., Campelo, C., Chamizo, F., García-Garrote, F., Pita, J., Barrios, J., Colmenarejo, C., Recacha, E., Pascual, A., Giner, S., López-Hontangas, J., Fernández, C., Bou, G., García-Castillo, M., Gijón, D., Cantón, R., Mulet, X., Larrosa, N., Vinado, B., Martínez, M., Rodríguez-Lucas, C., Raya, C., Tabla, V. O. D. L., García-López, M., Rivera, A., Arregui, I., Galán, F., Barrado, L., López-Lomba, M., Fernández, F., Baranda, C. S. D., Guerrero, C., Vasallo, F., Gracia, I., Calvo, J., Reina, M., Palop, B., Rodrigo, A., León, E., Colomina, J., Navarro, D., Bellido, J. M., Soria-Lozano, P., Aldea, C., Castillo, F., Cuevas, C. D. L., Cardeñoso, L., Molino, M. P. D., Coira, A., Garduño, E., Rúa-Gómez, M., Leiva, J., Sánchez-Romero, M., Moreno, L., Yagüe, G., Pérez-Seco, M., Rodríguez, R., Arenal, N., Quesada, M., Ramón, S., Prim, N., Cercenado, E., Alcalá, L., Irigoyen-von-Sierakowski, A., Rodríguez-Sánchez, B., & Marín, M. (2025). Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2025.107534

Source records